Illumina Says Co & Broad Institute Of MIT And Harvard Announce Research Partnership To Advance Single-Cell Sequencing; Expects Its Strategy To Enable Company To Accelerate Its Revenue Growth To High Single Digits By 2027
Portfolio Pulse from Benzinga Newsdesk
Illumina and the Broad Institute of MIT and Harvard have announced a research partnership to advance single-cell sequencing. Illumina expects this strategy to accelerate its revenue growth to high single digits by 2027.
August 13, 2024 | 3:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Illumina has announced a research partnership with the Broad Institute of MIT and Harvard to advance single-cell sequencing. The company expects this strategy to accelerate its revenue growth to high single digits by 2027.
The partnership with a prestigious institution like the Broad Institute is likely to enhance Illumina's research capabilities and market position in the biotech sector. The expectation of high single-digit revenue growth by 2027 is a positive indicator for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100